Sign up for the QMED & MD+DI Daily newsletter.
Name: Editas MedicineLocation: Cambridge, Massachusetts
December 8, 2015
1 Min Read
Name: Editas Medicine Location: Cambridge, Massachusetts What it Does: Uses genome editing, which allows sequence-targeted modification of DNA to potentially switch off or modify disease-creating genes to create new class of genomic medicine. GV Participation: New investor in $120 million Series B round. GV Investor: Krishna Yeshwant |
You May Also Like